You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Erlotinib Hydrochloride

Showing 1 - 25 of 2,499
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adult Solid Tumor Trial in Rochester (Erlotinib Hydrochloride, Irinotecan Hydrochloride)

Active, not recruiting
  • Adult Solid Neoplasm
  • Erlotinib Hydrochloride
  • Irinotecan Hydrochloride
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 12, 2023

Cirrhosis, Hepatocellular Carcinoma Trial in United States (Erlotinib, Erlotinib Hydrochloride, Laboratory Biomarker Analysis)

Active, not recruiting
Has Results
  • Cirrhosis
  • Hepatocellular Carcinoma
  • Jacksonville, Florida
  • +5 more
Feb 24, 2022

Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer AJCC v6 and v7 Trial in

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +3 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Dec 15, 2021

Lung Cancer Trial in Houston (DOTAP:Chol-TUSC2, Erlotinib, Dexamethasone)

Terminated
  • Lung Cancer
  • Houston, Texas
    UT MD Anderson Cancer Center
Feb 11, 2022

Recurrent NSCLC Trial in Sacramento, San Francisco (INC280, erlotinib HCl)

Completed
  • Recurrent Non-small Cell Lung Cancer
  • Sacramento, California
  • +1 more
Oct 11, 2021

Cirrhosis, Liver Trial (Erlotinib Hydrochloride)

Not yet recruiting
  • Cirrhosis, Liver
  • Erlotinib Hydrochloride
  • (no location specified)
Aug 23, 2021

NSCLC, Brain Cancer Trial in Tucson, Houston (Tarceva (Erlotinib HCl), Radiation Therapy)

Completed
Has Results
  • Non-small Cell Lung Cancer
  • Brain Cancer
  • Tarceva (Erlotinib hydrochloride)
  • Radiation Therapy
  • Tucson, Arizona
  • +1 more
Sep 14, 2021

Head Neck Cancer Trial in Houston (drug, other, behavioral)

Active, not recruiting
  • Head and Neck Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 31, 2022

Dermatologic Complications, Malignant Tumor, Pain Trial in Phoenix, Rochester (drug, other, procedure)

Active, not recruiting
Has Results
  • Dermatologic Complications
  • +2 more
  • menadione topical lotion
  • +3 more
  • Phoenix, Arizona
  • +1 more
Oct 6, 2021

Pancreatic Cancer Trial in Detroit, Houston (genistein, erlotinib HCl, gemcitabine HCl)

Completed
Has Results
  • Pancreatic Cancer
  • genistein
  • +2 more
  • Detroit, Michigan
  • +1 more
Feb 25, 2021

Lung Cancer, Metastatic Cancer Trial in Dallas (Erlotinib plus Romidepsin (8 mg/m^2), Erlotinib plus Romidepsin (10 mg/m^2),

Completed
Has Results
  • Lung Cancer
  • Metastatic Cancer
  • Erlotinib plus Romidepsin (8 mg/m^2)
  • +3 more
  • Dallas, Texas
    Simmons Comprehensive Cancer Center at University of Texas South
Jan 18, 2021

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer Trial in San Francisco, Columbus

Completed
Has Results
  • Adenocarcinoma of the Pancreas
  • +3 more
  • erlotinib hydrochloride
  • +2 more
  • San Francisco, California
  • +1 more
Jul 29, 2020

Stage IIIA NSCLC, Stage IIIB NSCLC Trial in Bronx, New York (drug, procedure, other)

Terminated
Has Results
  • Stage IIIA Non-Small Cell Lung Cancer
  • Stage IIIB Non-Small Cell Lung Cancer
  • Erlotinib Hydrochloride
  • +2 more
  • Bronx, New York
  • +2 more
Jun 24, 2020

Bladder Carcinoma, Recurrent Bladder Carcinoma Trial in United States (drug, other, procedure)

Terminated
Has Results
  • Bladder Carcinoma
  • Recurrent Bladder Carcinoma
  • Erlotinib Hydrochloride
  • +5 more
  • Baltimore, Maryland
  • +5 more
Jun 24, 2020

Breast Cancer Trial in Los Angeles (trastuzumab, erlotinib HCl)

Completed
Has Results
  • Breast Cancer
  • trastuzumab
  • erlotinib hydrochloride
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Sep 17, 2020

Stage IV Pancreatic Cancer Trial in United States (cixutumumab, erlotinib HCl, gemcitabine HCl)

Completed
Has Results
  • Stage IV Pancreatic Cancer
  • cixutumumab
  • +2 more
  • Jonesboro, Arkansas
  • +145 more
Jan 13, 2022

Bronchioloalveolar Carcinoma, Large Cell Lung Carcinoma, Lung Adenocarcinoma Trial in Sacramento, Worcester, Bronx (Erlotinib

Completed
Has Results
  • Bronchioloalveolar Carcinoma
  • +5 more
  • Erlotinib Hydrochloride
  • +2 more
  • Sacramento, California
  • +4 more
Aug 28, 2020

Recurrent Bladder Urothelial Carcinoma, Recurrent Renal Pelvis Urothelial Carcinoma, Recurrent Ureter Urothelial Carcinoma Trial

Completed
Has Results
  • Recurrent Bladder Urothelial Carcinoma
  • +19 more
  • Erlotinib Hydrochloride
  • Houston, Texas
    M D Anderson Cancer Center
Aug 21, 2020

Brain and CNS Tumors Trial in Los Angeles (Erlotinib + Sirolimus)

Completed
  • Brain and Central Nervous System Tumors
  • Erlotinib + Sirolimus
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Jul 29, 2020

Lung Cancer Trial in Canada (MET/VEGFR2 inhibitor Foretinib, erlotinib HCl, laboratory biomarker analysis)

Completed
  • Lung Cancer
  • MET/VEGFR2 inhibitor Foretinib
  • +2 more
  • Vancouver, British Columbia, Canada
  • +3 more
Apr 6, 2020

Prostate Cancer Trial in Los Angeles, Seattle (docetaxel, erlotinib HCl)

Completed
  • Prostate Cancer
  • Los Angeles, California
  • +2 more
Jul 30, 2020

Advanced Cancer Trial in Houston (Bevacizumab, Sorafenib, Erlotinib)

Completed
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 27, 2020

Pancreatic Cancer Trial in Baltimore (erlotinib HCl)

Completed
Has Results
  • Pancreatic Cancer
  • erlotinib hydrochloride
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
May 18, 2020

Liver Cancer Trial in Houston (Bevacizumab, Erlotinib)

Completed
Has Results
  • Liver Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 3, 2022

Bladder Cancer Trial in United States (dietary supplement, drug, other)

Completed
  • Bladder Cancer
  • Polyphenon E
  • +2 more
  • Phoenix, Arizona
  • +4 more
Jul 30, 2020